NEWS

Introducing the new MediPhorum

15 March 2023
MediPhorum
BioPhorum

The medical technology (MedTech) industry is a critical and complex sector. As highlighted during the Covid-19 pandemic, the MedTech industry provides a wide array of products and technologies that are vital to the safe and effective provision of care to many. Also, as seen over recent years, there is often the requirement for flexibility in supply, rapid development, and the introduction of new products to keep pace with global public health demands. 

To be successful, the industry must adapt to these needs while navigating evolving regulatory requirements. New regulatory frameworks, such as the Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR) as introduced within the European Union, invariably increase the regulatory burden and cost to device manufacturers.  Further complexity is introduced through the categorization of more than 7,000 medical device types, as recognized by the World Health Organization, under three broad regulatory categories (Class I, II, and III) (five including sub-categories in the EU).   This is an enormous challenge for the regulators that draft the regulations and monitor compliance and the MedTech manufacturers that need to ensure their products achieve cost-effective conformity.  

A long list of technical challenges, such as those relating to approved modalities and the supply of sterilization, further complicates the supply of MedTech-based products. Additionally, as our global population grows and ages, demand often increases out-of-step with available budgets, which inevitably results in an almost constant drive towards cheaper and/or more efficient solutions. Global high inflation has also impacted production and transportation costs, making it more difficult than ever before to ensure the profitable supply of critical medical technologies. 

More minds are better than one 

These factors, among many others, are driving significant frustration within many MedTech organizations. Companies often devote great effort to address these growing industry challenges – but in isolation. Although the precise issues are specific to the MedTech industry, similar complexity exists in other sectors, such as biopharmaceuticals. BioPhorum has extensive experience in driving efficient and effective cross-industry change within the biopharma industry to successfully address issues such as supply chain vulnerabilities and dual sourcing of raw materials. These results, and many more, have been generated via collaboration between multiple companies where knowledge is shared and solutions are derived for the benefit of all. BioPhorum’s experience is that the broader the expertise base, the more comprehensive and efficient the output. Often, the collective benefit is enhanced for participating companies, while greater rewards are also delivered in public health and for the multiple industry stakeholders: patients, healthcare professionals, health authorities, and regulators. 

MediPhorum – an open and safe environment to facilitate industry-wide collaboration 

BioPhorum has spent years distilling its unique collaborative approach and tuning this for use within the MedTech industry. As a result, MediPhorum by BioPhorum has been launched to bring together senior business leaders and subject matter experts across multiple MedTech disciplines, including drug delivery, wound management, urology, and diabetes care. MediPhorum’s mission is to better connect MedTech organizations to create industry-led solutions to its shared challenges. These include issues that increase the time and complexity taken to develop and market new medical devices and technologies, or cause complexity relating to the continued sale of established safe and effective medical devices. 

MediPhorum will add depth to new collaborations by helping subject matter experts from different device segment areas to share knowledge and enhance effective collaboration. If you are in the MedTech industry, can you afford not to collaborate? 

NEWS
A major milestone – a harmonized approach to product carbon footprint data
NEWS
Combination products – MediPhorum’s ‘state of the nation’ report
NEWS
Inaugural BioPhorum Quality face to face – get involved
NEWS
Forecasting the demand for single-use systems
NEWS
The new Drug Substance Strategic Value Framework – addressing industry pain points

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing